52 - Cell panel profiling of pre-clinical and clinical anti-cancer agents reveals conserved therapeutic clusters and differentiates the mechanism of action of different PI3K/mTOR, Aurora kinase and EZH2 inhibitors
| Autor: | Uitdehaag, J.C.M., De Roos, J.A.D.M., Prinsen, M.B.W., Willemsen-Seegers, N., De Vetter, J.R.F., Dylus, J., Van Doornmalen, A.M., Kooijman, J., Sawa, M., Van Gerwen, S.J.C., De Man, J., Buijsman, R.C., Zaman, G.J.R. |
|---|---|
| Zdroj: | In European Journal of Cancer December 2016 69 Supplement 1:S24-S24 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect